Thrombolytic therapy in peripheral arterial disease

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 4, Issue 3, 2004, Pages 249-258

  Giannini, D ^a   Balbarini, A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Peripheral arterial disease; Thrombolytic therapy

Indexed keywords

ABCIXIMAB; ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; PROUROKINASE; RECOMBINANT PLASMINOGEN ACTIVATOR; RETEPLASE; STAPHYLOKINASE; STREPTOKINASE; UROKINASE;

ARTERY EMBOLISM; ARTERY THROMBOSIS; BLEEDING; BRAIN HEMORRHAGE; BRONCHOSPASM; BYPASS SURGERY; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG BINDING; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG FEVER; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG INFUSION; DRUG MECHANISM; FIBRINOLYTIC THERAPY; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; LEG ARTERY; LEG REVASCULARIZATION; LIMB ISCHEMIA; LIMB SALVAGE; LOW DRUG DOSE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; REVIEW; RISK REDUCTION; SERUM SICKNESS; STENT; SURGICAL MORTALITY;

ARTERIAL OCCLUSIVE DISEASES; FIBRINOLYTIC AGENTS; FOOT; HUMANS; ISCHEMIA; LEG; PERIPHERAL VASCULAR DISEASES; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; THROMBOEMBOLISM; THROMBOLYTIC THERAPY;

EID: 4444347185     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006043336113     Document Type: Review

References (62)

1. Davies, B., Braithwaite, B.D., Birch, P.A., Poskitt, K.R., Heather, B.P., Earnshaw, J.J. Acute leg ischaemia in Gloucestershire. Br. J. Surg., 1997, 84, (4), 504-8.
2. Dormandy, J., Heeck, L., Vig, S. Acute limb ischemia. Semin. Vasc. Surg., 1999, 12, (2), 148-53. Review.
3. Ouriel, K., Veith, F.J., Sasahara, A.A. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N. Engl. J. Med., 1998, 16; 338, (16), 1105-11.
4. Rutherford, R.B., Flanigan, D.P., Gupta, J., Johnston, K.W., Karmody, A., Whittemore, A.D., et al. Suggested standards for reports dealing with lower extremity ischemia. J. Vasc. Surg., 1997, 26, 517-38.
5. Jivegard, L., Holm, J., Schersten, T. Acute limb ischemia due to arterial embolism or thrombosis influence of limb ischemia versus pre-existing cardiac disease on post-operative mortality rate J. Cardiovasc. Surg., 1988, 29, 32-36.
6. Tillet, W.S., Johnson, A.J., McCarthy, W.R. The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients. J. Clin. Invest., 1955, 34, 169-85.
7. Braithwaite, B.D., Petrik, P.V., Ritchie, A.W.S. and Earnshaw, J.J. Computerised angiographic analysis of the outcome of peripheral thrombolysis. Am. J. Surg., 1995, 170, pp. 131-175.
8. Tillett, W.S., Garner, R.L. The fibrinolytic activity of haemolytic streptococci. J. Exp. Med., 1933, 58, 489
9. Jostring, A., Barrh, U., Naidu, R. Changes of antistreptokinase titer following long-term streptokinase therapy. In: Martin M, Schoop W, Hirsh J. eds. Hans Huber, Vienna, 1978 pp110
10. McGrath, K., Hogan, C., Hunt, D., et al. Neutralising antibodies after streptokinase treatment for myocardial infarction: A persisting puzzle. Br. Heart J., 1995, 74, 122-123,.
11. Collen, D. Thrombolytic therapy. Thromb Haemost., 1997, 78, 742-746,.
12. Lee, H.S., Yule, S., McKenzie, A., et al. Hypersensitivity reactions to streptokinase in patients with high pre-treatment antistreptokinase antibody and neutralisation titres. Eur. Heart J., 1993, 14: 1640-1643,.
13. Bell, W.R. Jr: Evaluation of thrombolytic agents. Drugs., 1997, 54, (Suppl. 3), 11-16,.
14. Ouriel, K., Urokinase and the Food and Drug Administration. J. Vasc. Surg., 1999, 30, 957-8.
15. Credo, R.B., Burke, S.E., Burker, W.M. Recombinant urokinase: biochemistry, pharmacology and clinical experience. In: Sasahara AA, Loscalzo J ed. Marcel Dekker. NY, 1978, pp. 513-537.
16. Leopold, J.A., Keaney, J.F. Jr, Loscalzo, J. Pharmacology of thrombolytic agents. In Loscalzo, J., Schafer, AI (eds), Thrombosis and Hemorrhage. 2nd ed. Baltimore, Williams & Wilkins, 1998, pp. 1215-1258.
17. Tanswell, P., Tebbe, U., Neuhaus, K.L., et al. Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction. J. Am. Coll. Cardiol., 1992, 19, 1071-1075.
18. Noble, S., McTavish, D. Reteplase: A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Drugs, 1996, 52, 589-605.
19. Amery, A., Deloof, W., Vermylen, J., Verstraete, M. Outcome of recent thromboembolic occlusions of limb arteries treated with streptokinase. Br. Med. J., 1970, 12, 4 (736), 639-44.
20. Verstraete, M., Vermylen, J., Donati, M.B. The effect of streptokinase infusion in chronic arterial occlusions and stenoses. Ann. Intern. Med, 1971, 74, 377-82
21. Verhaeghe, R. Thrombolysis in arterial occlusion. Thromb. Haemost,. 1999 Sep; 82, Suppl. 1: 109-11. Review.
22. McNamara, T.O., Fische,r J.R. Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. AJR. Am. J. Roentgenol., 1985, 144, (4), 769-75.
23. Dotter, C.T., Rosch, J. and Seaman, A.J. Selective clot lysis with low-dose streptokinase. Radiology, 1974, 111, pp. 31-37.
24. Katzen, B.T. and van Breda, A. Low-dose streptokinase in the treatment of arterial occlusions. Am. J. Roentgenol., 1981, 136, pp. 1171-1178.
25. Valji, K., Roberts, A.C., Davis, G.B., Bookstein, J.J. Pulsed-spray thrombolysis of arterial and bypass graft occlusions. AJR. Am. J. Roentgenol., 1991, 156(3), 617-21.
26. Bookstein, J.J., Fellmeth, B., Roberts, A., Valji, K., Davis, G., Machado, T. Pulsed-spray pharmacomechanical thrombolysis: preliminary clinical results. AJR. Am. J. Roentgenol., 1989, May, 152(5), 1097-100.
27. Kandarpa, K., Drinker, P.A., Singer, S.J., Caramore, D. Forceful pulsatile local infusion of enzyme accelerates thrombolysis: in vivo evaluation of a new delivery system. Radiology, 1988, Sep, 168(3), 739-44.
28. Ouriel, K., Shortell, C.K., Azodo, M.V., Guiterrez, O.H., Marder, V.J. Acute peripheral arterial occlusion: predictors of success in catheter-directed thrombolytic therapy. Radiology, 1994, Nov, 193(2), 561-6.
29. Lawrence, P.F., Goodman, G.R. Thrombolytic therapy. Surg. Clin. North Am., 1992, 72(4), 899-918. Review.
30. Lupattelli, L., Barzi, F., Corneli, P., Lemmi, A., Mosca, S. Selective thrombolysis with low-dose urokinase in chronic arteriosclerotic obstructions. Cardiovasc. Intervent. Radiol., 1988, 11(3), 123-6.
31. Bell, W. Update on urokinase and streptokinase: a comparison of their efficacy and safety. Hosp. Formul., 1988, 23, 230-41.
32. Ouriel, K., Veith, F.J., Sasahara, A.A. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators. J. Vasc. Surg., 1996, 23(1), 64-73; discussion 74-5.
33. Graor, R., Risius, B., Lucas, F.V., Young, J.R., Ruschhaupt, W.F., Beven, E.G. and Grossbard, E.B. Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral arterial disease. Circulation, 1986, 74, Suppl. I pp. 1-15.
34. Verstraete, M., Hess, H., Mahler, F., Mietaschk, A., Roth, F.J., Schneider, E., Baert, A.L. and Verhaeghe, R. Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissue-type plasminogen activator - Report of a pilot trial. Eur. J. Vasc. Surg., 1988, 2, pp. 155-159.
35. Earnshaw, J.J., Westby, J.C., Gregson, R.H.S., Makin, G.S. and Hopkinson, B.R., Local thrombolytic therapy of peripheral arterial ischaemia with tissue plasminogen activator: a dose ranging study. Br. J. Surg., 1988, 75, pp. 1196-1200
36. Berridge, D.C., Gregson, R.H.S., Hopkinson, B.R. and Makin, G.S. Intra-arterial thrombolysis using recombinant tissue plasminogen activator (rt-PA), the optimal agant, at the optimal dose?. Eur. J. Vasc. Surg., 1989, 3, pp. 327-332.
37. Meyerovitz, M.F., Goldhaber, S.Z., Reagan, K., Polak, J.F., Kandarpa, K., Grassi, C.J. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology, 1990, 175, 75-8
38. Earnshaw, J.J. and Birch, P. Peripheral thrombolysis: state of the art. Cardiovasc. Surg., 1995, 3, pp. 357-367.
39. Weitz, J.I., Byrne, J., Clagett, G.P., Farkouh, M.E., Porter, J.M., Sackett, D.L., Strandness, D.E. and Taylor, L.M. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation, 1996, 94, pp. 3026-3049.
40. Ouriel, K., Kandarpa, K., Schuerr, D.M., Hultquist, M., Hodkinson, G., Wallin, B. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial. J. Vasc. Interv. Radiol., 1999, 10, (8), 1083-91.
41. Collen, D. Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent. Nat. Med., 1998, 4(3), 279-84. Review.
42. Drescher, P., Crain, M.R., Rilling, W.S. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study. J. Vasc. Interv. Radiol., 2002, 13(1), 37-43.
43. Suchkova, V., Siddiqi, F.N., Carstensen, E.L., Dalecki, D., Child, S., Francis, C.W. Enhancement of fibrinolysis with 40-kHz ultrasound. Circulation, 1998 8; 98(10), 1030-5.
44. Suchkova, V.N., Baggs, R.B., Francis, C.W. Effect of 40-kHz ultrasound on acute thrombotic ischemia in a rabbit femoral artery thrombosis model: enhancement of thrombolysis and improvement in capillary muscle perfusion. Circulation, 2000, 16; 101(19), 2296-301.
45. Sullivan, K.L., Gardiner, G.A. Jr, Kandarpa, K., Bonn, J., Shapiro, M.J., Carabasi, R.A. et al. Efficacy of thrombolysis in infrainguinal bypass grafts. Circulation, 1991, 83(2 Suppl.), 199-105.
46. Rath, B., Bennett, D.H. Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty. Br. Heart J., 1990, 63(1), 18-21.
47. Marder, V.J. Relevance of changes in blood fibrinolytic and coagulation parameters during thrombolytic therapy. Am. J. Med., 1987, 83(2A), 15-9.
48. Dormandy, J.A., Rutherford, R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J. Vasc. Surg., 2000, 31(1 Pt. 2), S1-S296. Review.
49. Ouriel, K., Shortell, C.K., De Weese, J.A., Green, R.M., Francis, C.W., Azodo, M.V.U. et al. A comparison of thrombolytic therapy with operative vascularization in the initial treatment of acute peripheral arterial ischemia. J. Vasc. Surg., 1994, 19, 1021-30.
50. The STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE Trial. Ann. Surg., 1994, 220, 251-68.
51. Weaver, F.A., Comerota, A.J., Yougblood, M., Froehlich, J., Hosking, J.D., Papanicolau, G. the Stile investigators. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J. Vasc. Surg., 1996, 24(4), 513-21; discussion 521-3.
52. Comerota, A.J., Weaver, F.A., Hosking, J.D., Froehlich, J., Folander, H., Sussman, B. et al. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. Am. J. Surg., 1996, 172(2), 105-12.
53. Korn, P., Khilnani, N.M., Fellers, J.C., Lee, T.Y., Winchester, P.A., Bush, H.L. et al. Thrombolysis for native arterial occlusions of the lower extremities: clinical outcome and cost. J. Vasc. Surg., 2001, 33(6), 1148-57.
54. Working Party on Thrombolysis in the Management of Limb Ischemia. Thrombolysis in the Management of Lower Limb Peripheral Arterial Occlusion - A Consensus Document. The American Journal of Cardiology, Vol. 81, Issue 2, 15 January 1998, Pages 207-218
55. McNamara, T.O., Goodwin, S.C., Kandarpa, K. Complications associated with thrombolysis. Semin. Intervent. Radiol., 1994, 2, 134-44
56. Belkin, M., Donaldson, M.C., Whittemore, A.D., Polak, J.F., Grassi, C.J., Harrington, D.P. et al. Observations on the use of thrombolytic agents for thrombotic occlusion of infrainguinal vein grafts. J. Vasc. Surg., 1990, 11(2), 289-94; discussion 295-6.
57. Eskridge, J.M., Becker, G.J., Rabe, F.E., Richmond, B.D., Holden, R.W., Yune, H.Y. et al. Catheter-related thrombosis and fibrinolytic therapy. Radiology, 1983, 149(2), 429-32.
58. Baglin, T.P., Luddington, R., Jennings, I., Richards, E.M. Thrombin generation and myocardial infarction during infusion of tissue-plasminogen activator. Lancet, 1993, 341(8843), 504-5.
59. McNamara, T.O., Bomberger, R.A., Merchant, R.F. Intra-arterial urokinase as the initial therapy for acutely ischemic lower limbs. Circulation, 1991, 83(2 Suppl.), I106-19.
60. Berridge, A.C., Makin, G.S., Hopkinson, B.R. Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage. Br. J. Surg., 1989, 76(12), 1230-3. Review.
61. Dawson, K., Amon, A., Brathwaite, B., Galland, R., Kendrick, R., Downes, M. et al. Stroke during intra-arterial thrombolysis: a survey of experience in the UK. Br. J. Surg., 1996, 83, 568
62. Sullivan, K.L., Gardiner, G.A. Jr, Shapiro, M.J., Bonn, J., Levin, D.C. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Radiology, 1993, 188, 861-7.